CDC COVID-19 Vaccine Effectiveness Collaborators

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024”.

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7308a5

N/A

0DataRank · unranked

77 citations

Amanda B. Payne, Wesley H. Self, Elizabeth Rowley, Kristin Dascomb, Malini B. DeSilva +94 more

Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025

MMWR Morbidity and Mortality Weekly Report(2025)10.15585/mmwr.mm7406a1

N/A

0DataRank · unranked

80 citations

Sean Chickery, A Webber, Toan C. Ong, Elizabeth Rowley, Malini B. DeSilva +94 more